Back
Worthington Enterprises Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
48
WOR
Worthington Enterprises
Last Price:
$40.77
Seasonality Move:
5.56%
Buy
60
BMRN
Biomarin Pharmaceutical
Last Price:
$65.65
Seasonality Move:
5.39%
Sell
48
Worthington Enterprises (WOR)
is a Sell
Is Worthington Enterprises a Buy, Sell or Hold?
-
The current Worthington Enterprises [WOR] share price is $40.78. The Score for WOR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
WOR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
-
The current Biomarin Pharmaceutical [BMRN] share price is $65.69. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
WOR Stock Price Chart
What is Worthington Enterprises's stock price today?
-
The Worthington Enterprises share price today is $40.78The current trend is relatively stagnant and WOR is experiencing slight selling pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $65.69Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
WOR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 51.31 | Buy |
Chaikin Money Flow: | -534020 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.27 - 41.45) | Buy |
Bollinger Bands (100): | (39.69 - 44.71) | Sell |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 48.8 | Sell |
Chaikin Money Flow: | 1709604 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (63.56 - 66.54) | Buy |
Bollinger Bands (100): | (64.13 - 84.07) | Sell |
WOR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.05 | Buy |
20-day SMA: | 40.63 | Buy |
50-day SMA: | 40.33 | Buy |
200-day SMA: | 48.93 | Sell |
8-day EMA: | 40.47 | Buy |
20-day EMA: | 40.46 | Buy |
50-day EMA: | 40.95 | Sell |
200-day EMA: | 47.17 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.79 | Sell |
20-day SMA: | 65.64 | Buy |
50-day SMA: | 66.69 | Sell |
200-day SMA: | 78.92 | Sell |
8-day EMA: | 65.67 | Buy |
20-day EMA: | 65.74 | Sell |
50-day EMA: | 67.62 | Sell |
200-day EMA: | 77.02 | Sell |
Worthington Enterprises Earnings Growth & WOR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.86 per share, and a decrease next year of $0.56 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.90 per share.
Worthington Enterprises Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |